HILE announced that the registration application for bone repair materials of its holding subsidiary, Shaanxi Ruisheng Biotechnology Co., Ltd., has been accepted by the National Medical Products Administration. This product is suitable for filling and repairing maxillofacial bone defects and alveolar bone defects, and is a key material in oral bone defect repair surgeries. The existing bone repair material products of Ruisheng Biotechnology will be supplemented, further enriching its product line. Currently, the product is still in the acceptance stage and is not expected to have a definitive impact on the company and Ruisheng Biotechnology's existing business and operating performance